Therapeutic Potential for Tetracyclines in the Treatment of COVID-19

Pharmacotherapy. 2020 May;40(5):487-488. doi: 10.1002/phar.2395. Epub 2020 May 4.

Publication types

  • Letter

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Betacoronavirus / drug effects
  • Betacoronavirus / physiology
  • Coronavirus Infections / drug therapy*
  • Humans
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Tetracyclines / therapeutic use*
  • Virus Replication / drug effects

Substances

  • Anti-Inflammatory Agents
  • Tetracyclines

Supplementary concepts

  • COVID-19
  • COVID-19 drug treatment
  • severe acute respiratory syndrome coronavirus 2